InvestLog
TYRA logo

TYRA

Tyra Biosciences, Inc.NASDAQHealthcare
$39.61+3.47%ClosedMarket Cap: $2.13B

As of 2026-04-06

Recent Analyst Ratings
DateFirmActionRatingPrevious
2026-03-20Piper Sandler—Overweight—
2026-02-17HC Wainwright & Co.—Buy—
2026-02-13Wedbush—Outperform—
2026-02-03Oppenheimer—Outperform—
2026-02-03Jefferies—Buy—
2026-01-23Piper Sandler—Overweight—
2025-12-16Wedbush—Outperform—
2025-08-22HC Wainwright & Co.—Buy—
2025-07-01HC Wainwright & Co.—Buy—
Forward Estimates
PeriodEPS Est.Revenue Est.# Analysts
Fri Dec 31$-2.61$1.2M6
Sun Dec 31$-2.72$16.5M6
Mon Dec 31$-2.67$45.3M4
Tue Dec 31$-0.96$243.0M2